Click for best price
Biologic Drugs Market Size, Share 2022
This report contains market size and forecasts of Biologic Drugs in global, including the following market information:
Global Biologic Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Biologic Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Biologic Drugs companies in 2021 (%)
The global Biologic Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Humira Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biologic Drugs include Roche, Abbott Laboratories, Johnson & Johnson, Merck & Co., Pfizer, Amgen, Sanofi, Novartis and Eli Lilly and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Biologic Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biologic Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biologic Drugs Market Segment Percentages, by Type, 2021 (%)
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
Global Biologic Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biologic Drugs Market Segment Percentages, by Application, 2021 (%)
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
Global Biologic Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Biologic Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biologic Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Biologic Drugs revenues share in global market, 2021 (%)
Key companies Biologic Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Biologic Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Abbott Laboratories
Johnson & Johnson
Merck & Co.
Pfizer
Amgen
Sanofi
Novartis
Eli Lilly
Amgen
| Report Attributes |
Report Details |
| Report Title |
Biologic Drugs Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
79 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biologic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biologic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biologic Drugs Overall Market Size
2.1 Global Biologic Drugs Market Size: 2021 VS 2028
2.2 Global Biologic Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Biologic Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Biologic Drugs Players in Global Market
3.2 Top Global Biologic Drugs Companies Ranked by Revenue
3.3 Global Biologic Drugs Revenue by Companies
3.4 Global Biologic Drugs Sales by Companies
3.5 Global Biologic Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Biologic Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Biologic Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biologic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Biologic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Biologic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biologic Drugs Market Size Markets, 2021 & 2028
4.1.2 Humira
4.1.3 Remicade
4.1.4 Rituxan
4.1.5 Enbrel
4.1.6 Lantus
4.1.7 Avastin
4.1.8 Herceptin
4.1.9 Others
4.2 By Type - Global Biologic Drugs Revenue & Forecasts
4.2.1 By Type - Global Biologic Drugs Revenue, 2017-2022
4.2.2 By Type - Global Biologic Drugs Revenue, 2023-2028
4.2.3 By Type - Global Biologic Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Biologic Drugs Sales & Forecasts
4.3.1 By Type - Global Biologic Drugs Sales, 2017-2022
4.3.2 By Type - Global Biologic Drugs Sales, 2023-2028
4.3.3 By Type - Global Biologic Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Biologic Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Biologic Drugs Market Size, 2021 & 2028
5.1.2 Diabetes
5.1.3 Inflammation
5.1.4 Auto-Immune Diseases
5.1.5 Blood Diseases
5.1.6 Cardiovascular Diseases
5.1.7 Others
5.2 By Application - Global Biologic Drugs Revenue & Forecasts
5.2.1 By Application - Global Biologic Drugs Revenue, 2017-2022
5.2.2 By Application - Global Biologic Drugs Revenue, 2023-2028
5.2.3 By Application - Global Biologic Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Biologic Drugs Sales & Forecasts
5.3.1 By Application - Global Biologic Drugs Sales, 2017-2022
5.3.2 By Application - Global Biologic Drugs Sales, 2023-2028
5.3.3 By Application - Global Biologic Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Biologic Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Biologic Drugs Market Size, 2021 & 2028
6.2 By Region - Global Biologic Drugs Revenue & Forecasts
6.2.1 By Region - Global Biologic Drugs Revenue, 2017-2022
6.2.2 By Region - Global Biologic Drugs Revenue, 2023-2028
6.2.3 By Region - Global Biologic Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Biologic Drugs Sales & Forecasts
6.3.1 By Region - Global Biologic Drugs Sales, 2017-2022
6.3.2 By Region - Global Biologic Drugs Sales, 2023-2028
6.3.3 By Region - Global Biologic Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Biologic Drugs Revenue, 2017-2028
6.4.2 By Country - North America Biologic Drugs Sales, 2017-2028
6.4.3 US Biologic Drugs Market Size, 2017-2028
6.4.4 Canada Biologic Drugs Market Size, 2017-2028
6.4.5 Mexico Biologic Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Biologic Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Biologic Drugs Sales, 2017-2028
6.5.3 Germany Biologic Drugs Market Size, 2017-2028
6.5.4 France Biologic Drugs Market Size, 2017-2028
6.5.5 U.K. Biologic Drugs Market Size, 2017-2028
6.5.6 Italy Biologic Drugs Market Size, 2017-2028
6.5.7 Russia Biologic Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Biologic Drugs Market Size, 2017-2028
6.5.9 Benelux Biologic Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Biologic Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Biologic Drugs Sales, 2017-2028
6.6.3 China Biologic Drugs Market Size, 2017-2028
6.6.4 Japan Biologic Drugs Market Size, 2017-2028
6.6.5 South Korea Biologic Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Biologic Drugs Market Size, 2017-2028
6.6.7 India Biologic Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Biologic Drugs Revenue, 2017-2028
6.7.2 By Country - South America Biologic Drugs Sales, 2017-2028
6.7.3 Brazil Biologic Drugs Market Size, 2017-2028
6.7.4 Argentina Biologic Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biologic Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Biologic Drugs Sales, 2017-2028
6.8.3 Turkey Biologic Drugs Market Size, 2017-2028
6.8.4 Israel Biologic Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Biologic Drugs Market Size, 2017-2028
6.8.6 UAE Biologic Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Biologic Drugs Major Product Offerings
7.1.4 Roche Biologic Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Roche Key News
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Corporate Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Biologic Drugs Major Product Offerings
7.2.4 Abbott Laboratories Biologic Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Abbott Laboratories Key News
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Corporate Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Biologic Drugs Major Product Offerings
7.3.4 Johnson & Johnson Biologic Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Johnson & Johnson Key News
7.4 Merck & Co.
7.4.1 Merck & Co. Corporate Summary
7.4.2 Merck & Co. Business Overview
7.4.3 Merck & Co. Biologic Drugs Major Product Offerings
7.4.4 Merck & Co. Biologic Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Merck & Co. Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Biologic Drugs Major Product Offerings
7.5.4 Pfizer Biologic Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Biologic Drugs Major Product Offerings
7.6.4 Amgen Biologic Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Amgen Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Biologic Drugs Major Product Offerings
7.7.4 Sanofi Biologic Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Sanofi Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Biologic Drugs Major Product Offerings
7.8.4 Novartis Biologic Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Novartis Key News
7.9 Eli Lilly
7.9.1 Eli Lilly Corporate Summary
7.9.2 Eli Lilly Business Overview
7.9.3 Eli Lilly Biologic Drugs Major Product Offerings
7.9.4 Eli Lilly Biologic Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Eli Lilly Key News
7.10 Amgen
7.10.1 Amgen Corporate Summary
7.10.2 Amgen Business Overview
7.10.3 Amgen Biologic Drugs Major Product Offerings
7.10.4 Amgen Biologic Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Amgen Key News
8 Global Biologic Drugs Production Capacity, Analysis
8.1 Global Biologic Drugs Production Capacity, 2017-2028
8.2 Biologic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Biologic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biologic Drugs Supply Chain Analysis
10.1 Biologic Drugs Industry Value Chain
10.2 Biologic Drugs Upstream Market
10.3 Biologic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biologic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Biologic Drugs in Global Market
Table 2. Top Biologic Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Biologic Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Biologic Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Biologic Drugs Sales by Companies, (K Units), 2017-2022
Table 6. Global Biologic Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Biologic Drugs Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Biologic Drugs Product Type
Table 9. List of Global Tier 1 Biologic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biologic Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Biologic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Biologic Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Biologic Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Biologic Drugs Sales (K Units), 2017-2022
Table 15. By Type - Global Biologic Drugs Sales (K Units), 2023-2028
Table 16. By Application ? Global Biologic Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Biologic Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Biologic Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Biologic Drugs Sales (K Units), 2017-2022
Table 20. By Application - Global Biologic Drugs Sales (K Units), 2023-2028
Table 21. By Region ? Global Biologic Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Biologic Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Biologic Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Biologic Drugs Sales (K Units), 2017-2022
Table 25. By Region - Global Biologic Drugs Sales (K Units), 2023-2028
Table 26. By Country - North America Biologic Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Biologic Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Biologic Drugs Sales, (K Units), 2017-2022
Table 29. By Country - North America Biologic Drugs Sales, (K Units), 2023-2028
Table 30. By Country - Europe Biologic Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Biologic Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Biologic Drugs Sales, (K Units), 2017-2022
Table 33. By Country - Europe Biologic Drugs Sales, (K Units), 2023-2028
Table 34. By Region - Asia Biologic Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Biologic Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Biologic Drugs Sales, (K Units), 2017-2022
Table 37. By Region - Asia Biologic Drugs Sales, (K Units), 2023-2028
Table 38. By Country - South America Biologic Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Biologic Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Biologic Drugs Sales, (K Units), 2017-2022
Table 41. By Country - South America Biologic Drugs Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Biologic Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Biologic Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Biologic Drugs Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Biologic Drugs Sales, (K Units), 2023-2028
Table 46. Roche Corporate Summary
Table 47. Roche Biologic Drugs Product Offerings
Table 48. Roche Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Abbott Laboratories Corporate Summary
Table 50. Abbott Laboratories Biologic Drugs Product Offerings
Table 51. Abbott Laboratories Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Johnson & Johnson Corporate Summary
Table 53. Johnson & Johnson Biologic Drugs Product Offerings
Table 54. Johnson & Johnson Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Merck & Co. Corporate Summary
Table 56. Merck & Co. Biologic Drugs Product Offerings
Table 57. Merck & Co. Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Biologic Drugs Product Offerings
Table 60. Pfizer Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Amgen Corporate Summary
Table 62. Amgen Biologic Drugs Product Offerings
Table 63. Amgen Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Sanofi Corporate Summary
Table 65. Sanofi Biologic Drugs Product Offerings
Table 66. Sanofi Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Novartis Corporate Summary
Table 68. Novartis Biologic Drugs Product Offerings
Table 69. Novartis Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Eli Lilly Corporate Summary
Table 71. Eli Lilly Biologic Drugs Product Offerings
Table 72. Eli Lilly Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Amgen Corporate Summary
Table 74. Amgen Biologic Drugs Product Offerings
Table 75. Amgen Biologic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Biologic Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 77. Global Biologic Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 78. Global Biologic Drugs Production by Region, 2017-2022 (K Units)
Table 79. Global Biologic Drugs Production by Region, 2023-2028 (K Units)
Table 80. Biologic Drugs Market Opportunities & Trends in Global Market
Table 81. Biologic Drugs Market Drivers in Global Market
Table 82. Biologic Drugs Market Restraints in Global Market
Table 83. Biologic Drugs Raw Materials
Table 84. Biologic Drugs Raw Materials Suppliers in Global Market
Table 85. Typical Biologic Drugs Downstream
Table 86. Biologic Drugs Downstream Clients in Global Market
Table 87. Biologic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biologic Drugs Segment by Type
Figure 2. Biologic Drugs Segment by Application
Figure 3. Global Biologic Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biologic Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biologic Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Biologic Drugs Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Biologic Drugs Revenue in 2021
Figure 9. By Type - Global Biologic Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Biologic Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Biologic Drugs Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Biologic Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Biologic Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Biologic Drugs Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Biologic Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Biologic Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Biologic Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Biologic Drugs Sales Market Share, 2017-2028
Figure 19. US Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Biologic Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Biologic Drugs Sales Market Share, 2017-2028
Figure 24. Germany Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Biologic Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Biologic Drugs Sales Market Share, 2017-2028
Figure 33. China Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Biologic Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Biologic Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Biologic Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Biologic Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Biologic Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Biologic Drugs Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Biologic Drugs by Region, 2021 VS 2028
Figure 50. Biologic Drugs Industry Value Chain
Figure 51. Marketing Channels
